Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 21

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 21
---
 the proposal to approve the adjournment of the Special                                                                   
 Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the Merger Agreement Proposal (the “Adjournment Proposal”). |

| Q: | How does the Enfusion Board of Directors recommend that I vote at the Special Meeting? |

| A: | The board of directors of Enfusion (the “Enfusion Board”) unanimously recommends that Enfusion 
 Stockholders vote “FOR” the Merger Agreement Proposal and “FOR” the Adjournment Proposal.      |

7

| Q: | What do I need to do now? |

| A: | After carefully reading and considering the information contained in this Proxy Statement/Prospectus, please                                                                                                                                   
 submit your proxy as soon as possible so that your shares of Enfusion Common Stock or Enfusion Class B Common Stock will be represented and voted at the Special Meeting. Please follow the instructions set forth on the proxy card or on the 
 voting instruction card provided by the record holder if your shares are held in “street name” by your bank, brokerage firm or other nominee.                                                                                                  |

| Q: | When and where is the Special Meeting of the Enfusion Stockholders? |

| Q: | Who can vote at the Special Meeting? |

| Q: | How many votes do I have? |

| A: | You are entitled to one vote on each matter properly brought before the Special Meeting for each share of                                                                                                                                      
 Enfusion Common Stock or Enfusion Class B Common Stock you hold or beneficially own as of the close of business on the record date. As of the close of business on the record date, there were 129,847,448 shares of Enfusion Common Stock and 
 Enfusion Class B Common Stock outstanding and owned by stockholders (i.e., excluding shares of Enfusion Common Stock held in treasury by Enfusion) held by 7 holders of record.                                                                |

| Q: | What constitutes a quorum for the Special Meeting? |

| A: | The presence of holders of shares representing at least a majority of the total outstanding shares of Enfusion                                                                                                                                      
 Common Stock and Enfusion Class B Common Stock on the record date entitled to vote at the Special Meeting, represented virtually or by proxy, constitute a quorum. Enfusion Stockholders choosing to abstain from voting will be treated as present 
 for purposes of determining whether a quorum is present, but will not be counted as votes cast “FOR” any matter.                                                                                                                                    |

|